Literature DB >> 23337504

miR-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42.

Yuefeng Li1, Xiaolan Zhu, Wenlin Xu, Dongqing Wang, Jinchuan Yan.   

Abstract

MicroRNAs are small non-coding RNA molecules that play important roles in the multistep process of colorectal carcinoma (CRC) development. However, the miRNA-mRNA regulatory network is far from being fully understood. The objective of this study was to investigate the expression and the biological roles of miR-330 in colorectal cancer cells. Cdc42, one of the best characterized members of the Rho GTPase family, was found to be up-regulated in several types of human tumors including CRC and has been implicated in cancer initiation and progression. In the present study, we identified miR-330, as a potential regulator of Cdc42, was found to be inversely correlated with Cdc42 expression in colorectal cancer cell lines. Ectopic expression of miR-330 down-regulated Cdc42 expression at both protein and mRNA level, mimicked the effect of Cdc42 knockdown in inhibiting proliferation, inducing G1 cell cycle arrest and apoptosis of the colorectal cancer cells, whereas restoration of Cdc42 could partially attenuate the effects of miR-330. In addition, elevated expression of miR-330 could suppress the immediate downstream effectors of Cdc42 and inhibit the growth of colorectal cancer cells in vivo. To sum up, our results establish a role of miR-330 in negatively regulating Cdc42 expression and colorectal cancer cell proliferation. They suggest that manipulating the expression level of Cdc42 by miR-330 has the potential to influence colorectal cancer progression.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23337504     DOI: 10.1016/j.bbrc.2013.01.016

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  MicroRNA-330-3p functions as an oncogene in human esophageal cancer by targeting programmed cell death 4.

Authors:  Hui Meng; Kai Wang; Xuedan Chen; Xingying Guan; Liwen Hu; Gang Xiong; Juan Li; Yun Bai
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

Review 2.  MicroRNAs in colorectal cancer as markers and targets: Recent advances.

Authors:  Jing-Jia Ye; Jiang Cao
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

3.  microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.

Authors:  Niuniu Sun; Lin Ye; Tingmin Chang; Xiaojing Li; Xiumin Li
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

4.  Rpph1 Upregulates CDC42 Expression and Promotes Hippocampal Neuron Dendritic Spine Formation by Competing with miR-330-5p.

Authors:  Yifei Cai; Ziling Sun; Huizhen Jia; Hongxue Luo; Xiaoyang Ye; Qi Wu; Yi Xiong; Wei Zhang; Jun Wan
Journal:  Front Mol Neurosci       Date:  2017-02-07       Impact factor: 5.639

5.  Roles of microRNA-330 and Its Target Gene ING4 in the Development of Aggressive Phenotype in Hepatocellular Carcinoma Cells.

Authors:  Xiao Hu; Yujie Feng; Lin Sun; Linlin Qu; Chuandong Sun
Journal:  Dig Dis Sci       Date:  2017-01-03       Impact factor: 3.199

6.  MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines.

Authors:  Su-Chen Li; Azita Monazzam; Masoud Razmara; Xia Chu; Peter Stålberg; Britt Skogseid
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

7.  Up-regulation of matrix metalloproteinases in a mouse model of chemically induced colitis-associated cancer: the role of microRNAs.

Authors:  Feiyan Ai; Xuemei Zhang; Xiayu Li; Zailong Qin; Qiurong Ye; Li Tian; Anliu Tang; Nan Li; Guiyuan Li; Jian Ma; Shourong Shen
Journal:  Oncotarget       Date:  2015-03-10

Review 8.  miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents.

Authors:  Volker Baumann; Johannes Winkler
Journal:  Future Med Chem       Date:  2014       Impact factor: 3.808

9.  MicroRNA-330-5p as a Putative Modulator of Neoadjuvant Chemoradiotherapy Sensitivity in Oesophageal Adenocarcinoma.

Authors:  Becky A S Bibby; John V Reynolds; Stephen G Maher
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

10.  MiR-330-mediated regulation of SH3GL2 expression enhances malignant behaviors of glioblastoma stem cells by activating ERK and PI3K/AKT signaling pathways.

Authors:  Yilong Yao; Yixue Xue; Jun Ma; Chao Shang; Ping Wang; Libo Liu; Wenjing Liu; Zhen Li; Shengtao Qu; Zhiqing Li; Yunhui Liu
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.